Legal Representation
Attorney
Howard N. Aronson
USPTO Deadlines
Next Deadline
In Grace Period
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20190820)
Due Date
August 20, 2025
Grace Period Ends
February 20, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 20, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | Loading... |
| Jan 3, 2020 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Dec 13, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Dec 13, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Nov 20, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 20, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 4, 2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 4, 2019 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 15, 2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 26, 2019 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 16, 2019 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 25, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 25, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 25, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 26, 2019 | CORN | I | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
| Feb 22, 2019 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 15, 2019 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Feb 4, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 4, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jan 23, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 22, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 19, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 15, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 15, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 14, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Jan 10, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations, namely, pharmaceutical preparations for the treatment of inflammation
Classification
International Classes
005